APULI MARICEL (Chief Accounting Officer) reported 1 transaction at BRIDGEBIO PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/18/2026ACC: 0001470831-26-000835
Officer· Chief Accounting Officer
Since Feb 2026
-4.71K
Net shares
Net seller
$376.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.71K
Price / share
$79.86
Trade value
$376.46K
% of position
3.7%
8/16/2026
127.40K→122.69K
Total
Net shares
−4.71K
Net value
-$376.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2026 | F · Tax Withholding | −4.71K | $79.86 | $376.46K | 3.7% | 127.40K | 122.69K |
| Total | −4.71K | -$376.46K | ||||||
Derivative Transactions0
No derivative transactions reported